Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia

Catia Cillóniz1, Santiago Ewig, Rosario Menéndez

  • 1Department of Pneumology, Institut del Tórax, Hospital Clinic, IDIBAPS, University of Barcelona, Villarroel 170, Barcelona 08036, Spain.

Abstract

Insights

Bacterial co-infection was common in patients with influenza A H1N1 pneumonia. While chronic obstructive pulmonary disease (COPD) and high platelets predicted co-infection, it did not increase mortality.

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Critical Care Medicine

Background:

  • Bacterial co-infection significantly contributes to severe illness and death during influenza pandemics.
  • Investigating influenza A H1N1 pneumonia with bacterial co-infection is crucial for understanding patient outcomes.

Purpose of the Study:

  • To determine the incidence, risk factors, and outcomes of bacterial co-infection in hospitalized patients with influenza A H1N1 pneumonia.
  • To compare outcomes between patients with and without bacterial co-infection.

Main Methods:

  • Prospective observational study of hospitalized patients diagnosed with influenza A H1N1 virus and community-acquired pneumonia (CAP).
  • Comparison of clinical characteristics and outcomes between patients with and without bacterial co-infection.

Main Results:

  • Bacterial co-infection occurred in 33% of 128 patients with influenza A H1N1 pneumonia; Streptococcus pneumoniae was the most common pathogen.
  • Chronic obstructive pulmonary disease (COPD) and elevated platelet counts were predictors of bacterial co-infection.
  • Hospital mortality was 9%, with age, septic shock, and mechanical ventilation as mortality predictors. Bacterial co-infection did not significantly impact hospital mortality (7% vs. 11%).

Conclusions:

  • Bacterial co-infection is frequent in influenza A H1N1 pneumonia, with COPD and increased platelet count as key predictors.
  • Despite presenting with higher severity scores, bacterial co-infection did not lead to increased mortality in these patients.

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps: